Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Clinical trial NCT01460875 · COMPLETED

Trial details

NCT number: NCT01460875
Sponsor: William Carson
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage IA Skin Melanoma Stage IB Skin Melanoma Stage IIA Skin Melanoma Stage IIB Skin Melanoma Stage IIC Skin Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma

Start date: 2008-04-22
Primary completion: 2014-01-05
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.